← Study Library
Animal · 2021
Preclinicalcounts toward this tierBetaine Attenuates Osteoarthritis by Inhibiting Osteoclastogenesis and Angiogenesis in Subchondral Bone
Yajun W, et al. · Frontiers in Pharmacology
Preclinicalcounts toward this tier
Betaine reduced cartilage proteoglycan loss, lowered OARSI histology scores, decreased MMP-13/collagen-X-positive cells and normalised subchondral bone remodelling and aberrant angiogenesis, apparently via ROS/MAPK-dependent inhibition of osteoclastogenesis.
- Population
- Mice with surgically induced (ACLT) knee OA; osteoclast cultures
- Intervention
- Betaine treatment after OA induction
- Comparator
- Untreated ACLT mice
- Limitations
- Mouse surgical-OA model; abstract does not state dose or group sizes; no human data.
Cited by
1 entry references this study
- TMG / betainePRECL.
Supplements → Vitamins & cofactors · key study